Adherium - FloodGate Medical

Developing new generation technology and working to deliver value to payers and providers

About Us

Adherium Limited is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers.

Adherium’s Hailie^®Smartinhaler^® sensor technology and cloud-based data platform provides real-time feedback on patients’ use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place.

Look at the Leaders of Adherium

Dawn Bitz

Chief Executive Officer

Tess Law

Head of Human Resources

John Perry

Chief Commercial Officer

Our Technology

The Hailie^®Remote Patient Monitoring (RPM) Solution

Smartinhaler^® technology clinically proven with strong evidence-based, investing to enable physiological data and extend therapeutic coverage.

The Hailie^® Smartinhaler^®Sensors

Adherium’s clinically supported Hailie^® technology platform has extensive inhaled device coverage that works for Rescuer/Reliever and Preventer inhalers.

The Hailie^®Solution: Clinically Proven Effective

The Hailie^® solution is the world’s most clinically supported asthma adherence solution.

The Hailie^® solution is independently shown to:

Increase adherence to preventative medication by 180% in children and 59% in adults.
Reduce severe exacerbations in adults by 61%.
Contribute to significant improvements in quality of life for people with chronic asthma.

The Hailie^®platform has been referenced in more than 100 peer-reviewed publications involving over 13,000 patients.

Company Spotlight Video

News

ATS 2026

Two independent studies were presented at the American Thoracic Society (ATS) 2026 International Conference this week, featuring data generated using Adherium’s Hailie® Smartinhaler® technology, reinforcing the growing role of objective respiratory monitoring in improving patient outcomes while reducing healthcare utilisation and cost.

iCARE study demonstrates reductions in hospitalisations and cost of care

Adherium has released new real-world outcomes from the iCARE respiratory care study, highlighting the impact of the Hailie® Smartinhaler® platform in improving outcomes for patients with asthma and COPD.

Completion of Placement and Institutional Entitlement Offer

Adherium (ASX:ADR) has announced that it has received firm commitments for a total of $6.70 million under the Placement and institutional component of the Accelerated Pro-Rata Non-Renounceable Entitlement Offer (ANREO).

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!